2007
DOI: 10.1016/s0140-6736(07)60712-0
|View full text |Cite
|
Sign up to set email alerts
|

Antiplatelet agents for prevention of pre-eclampsia: a meta-analysis of individual patient data

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

14
565
2
51

Year Published

2008
2008
2023
2023

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 926 publications
(632 citation statements)
references
References 46 publications
14
565
2
51
Order By: Relevance
“…While there is currently no effective preventative measure, a recent meta-analysis has suggested that low-dose aspirin may reduce the incidence of pre-eclampsia by 10%. 44,45 Early identification of women at risk of pre-eclampsia facilitates targeted surveillance and intervention. 46,47 There are likely to be significant advantages in predicting preeclampsia in the first, as opposed to the second trimester; given that the disease process (failure of adequate trophoblastic invasion) is already established by the mid-second trimester, it seems likely that any successful preventative measure will need to be instituted as early in pregnancy as possible.…”
Section: Discussionmentioning
confidence: 99%
“…While there is currently no effective preventative measure, a recent meta-analysis has suggested that low-dose aspirin may reduce the incidence of pre-eclampsia by 10%. 44,45 Early identification of women at risk of pre-eclampsia facilitates targeted surveillance and intervention. 46,47 There are likely to be significant advantages in predicting preeclampsia in the first, as opposed to the second trimester; given that the disease process (failure of adequate trophoblastic invasion) is already established by the mid-second trimester, it seems likely that any successful preventative measure will need to be instituted as early in pregnancy as possible.…”
Section: Discussionmentioning
confidence: 99%
“…8 Accurate prediction of pre-eclampsia and intrauterine growth restriction is crucial to allow judicious allocation of resources for monitoring and preventive treatment to improve maternal and perinatal outcomes. 9,10 However, studies investigating the predictive accuracy of uterine artery Doppler indices (Box 1) have revealed considerably varied results. Thus, it is questionable whether uterine artery Doppler ultrasonography should be used as a predictive test.…”
Section: 5mentioning
confidence: 99%
“…Currently, no pharmacologic treatment or management strategy has been shown to be effective in preventing preeclampsia or intrauterine growth restriction or ameliorating their complications. Research into treatment with acetylsalicylic acid, which is inexpensive and readily available, has shown a small preventive effect (relative risk 0.9 for both preeclampsia and intrauterine growth restriction) 10 in the absence of any serious side effects. In this case, a false-negative test result is potentially more harmful than a false-positive test result.…”
Section: -39mentioning
confidence: 99%
“…Moreover, lupus nephritis has also been specifically linked to this complication in a recent systematic review (7). Low-dose aspirin has been shown to significantly reduce the frequency of preeclampsia, the risk of delivery before 34 weeks, and serious adverse obstetric outcomes in high-risk women (8), and would similarly be recommended. Further, hydroxychloroquine reduced preeclampsia in a small trial in pregnant women with lupus (9).…”
Section: To the Editormentioning
confidence: 99%